Luciane de Souza Velasque

Luciane de Souza Velasque

Auto-generated profile, based on publicly available information

Luciane de Souza Velasque

Universidade Federal do Estado do Rio de Janeiro

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RERodrigo Otavio da Silva Escada
Rodrigo Otavio da Silva Escada
LVLuciane Velasque
Luciane Velasque
SRSayonara Rocha Ribeiro
Sayonara Rocha Ribeiro
SCSandra W. Cardoso
Sandra W. Cardoso
LMLuana Monteiro Spindola Marins
Luana Monteiro Spindola Marins
VVValdiléa Gonçalves Veloso
Valdiléa Gonçalves Veloso
Tuberculosis is the most frequent opportunistic infection and the leading cause of death among persons living with HIV in several low and middle-income countries. Mortality rates during tuberculosis treatment and death causes among HIV-1/TB co-infected patients may differ based on the immunosuppression severity, timing of diagnosis and prompt initiation of tuberculosis and antiretroviral therapy. This was a retrospective observational study conducted in the clinical cohort of patients with HIV-1/Aids of the National Institute of Infectious Diseases Evandro Chagas, Rio de Janeiro, Brazil. All HIV-1 infected patients who started combination antiretroviral therapy up to 30 days before or within 180 days after the start of tuberculosis treatment from 2000 to 2010 were eligible. Causes of death were categorized according to the "Coding Causes of Death in HIV” (CoDe) protocol. The Cox model was used to estimate the hazard ratio (HR) of selected mortality variables. A total of 310 patients were included. Sixty-four patients died during the study period. Mortality rate following tuberculosis treatment initiation was 44 per 100 person-years within the first 30 days, 28.1 per 100 person-years within 31 and 90 days, 6 per 100 person-years within 91 and 365 days and 1.6 per 100 person-years after 365 days. Death probability within one year from tuberculosis treatment initiation was approximately 13%. In the adjusted analysis the associated factors with mortality were: CD4 ≤ 50 cells/mm3 (HR: 3.10; 95% CI: 1.720 to 5.580; p = 0.00); mechanical ventilation (HR: 2.81; 95% CI: 1.170 to 6.760; p = 0.02); and disseminated tuberculosis (HR: 3.70; 95% CI: 1.290 to 10.590, p = 0.01). Invasive bacterial disease was the main immediate cause of death (46.9%). Our results evidence the high morbidity and mortality among patients co-infected with HIV-1 and tuberculosis in Rio de Janeiro, Brazil. During the first year following tuberculosis diagnosis, mortality was the highest within the first 3 months, being invasive bacterial infection the major cause of death. In order to successfully intervene in this scenario, it is utterly necessary to address the social determinants of health contributing to the inequitable health care access faced by this population.

22 June 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
RFRita D Fernández-Medina
Rita D Fernández-Medina
JRJosé M.C. Ribeiro
José M.C. Ribeiro
CCClaudia Carareto
Claudia Carareto
LVLuciane Velasque
Luciane Velasque
CSCláudio José Struchiner
Cláudio José Struchiner
Background: Transposable elements (TEs), both DNA transposons and retrotransposons, are genetic elements with the main characteristic of being able to mobilize and amplify their own representation within genomes, utilizing different mechanisms of transposition. An almost universal feature of TEs in eukaryotic genomes is their inability to transpose by themselves, mainly as the result of sequence degeneration (by either mutations or deletions). Most of the elements are thus either inactive or non-autonomous. Considering that the bulk of some eukaryotic genomes derive from TEs, they have been conceived as “TE graveyards.” It has been shown that once an element has been inactivated, it progressively accumulates mutations and deletions at neutral rates until completely losing its identity or being lost from the host genome; however, it has also been shown that these “neutral sequences” might serve as raw material for domestication by host genomes.Results: We have analyzed the sequence structural variations, nucleotide divergence, and pattern of insertions and deletions of several superfamilies of TEs belonging to both class I (long terminal repeats [LTRs] and non-LTRs [NLTRs]) and II in the genome ofAnopheles gambiae, aiming at describing the landscape of deterioration of these elements in this particular genome. Our results describe a great diversity in patterns of deterioration, indicating lineage-specific differences including the presence of Solo-LTRs in the LTR lineage, 5′-deleted NLTRs, and several non-autonomous and MITEs in the class II families. Interestingly, we found fragments of NLTRs corresponding to the RT domain, which preserves high identity among them, suggesting a possible remaining genomic role for these domains.Conclusions: We show here that the TEs in theAn. gambiaegenome deteriorate in different ways according to the class to which they belong. This diversity certainly has implications not only at the host genomic level but also at the amplification dynamic and evolution of the TE families themselves.

15 November 2020 in AIDS Care
Verified
Journal Article
Open access
EWErin C. Wilson
Erin C. Wilson
EJEmilia Moreira Jalil
Emilia Moreira Jalil
RMRonaldo I. Moreira
Ronaldo I. Moreira
LVLuciane Velasque
Luciane Velasque
CCCristiane V. Castro
Cristiane V. Castro
BGBeatriz Grinsztejn
Beatriz Grinsztejn
Adult trans women in Brazil are highly impacted by HIV, but little is known about risk for young trans women. Our study was conducted to compare the HIV prevalence and correlates of risk for young trans women ages 18–24 years old to adult trans women in Brazil. Trans women were recruited from Rio de Janeiro and Baixada (the metropolitan area of Rio de Janeiro), Brazil (N = 345). Youth ages 18–24 years of age had significantly greater odds of being HIV negative than adults (OR 0.4, 95% CI 0.2–0.6, p = 0.0002), but significantly lower odds of having post-exposure prophylaxis (PEP) knowledge (OR 0.5, 95% CI:0.3–0.9, p = 0.02) and PrEP awareness (OR 0.5, 95% CI: 0.3–0.8, p = 0.01). Young trans women also had significantly higher odds of using substances (OR 1.8, 95% CI 1.1–2.9, p = 0.02) and condomless anal intercourse with their last three sexual partners (OR 1.8, 95% CI: 1.1–3.0, p = 0.03) compared to adults. Already by age 24, one in four trans women in Brazil were infected with HIV pointing to a new generation at high risk of acquiring HIV. HIV prevention interventions are needed to change the healthcare system to reach and engage young trans women.

14 October 2021 in Educational Studies in Mathematics
Verified
Journal Article
Closed access
PDF file
ASAlexandre Sousa da Silva
Alexandre Sousa da Silva
MBMaria Tereza Serrano Barbosa
Maria Tereza Serrano Barbosa
LVLuciane de Souza Velasque
Luciane de Souza Velasque
DADavi da Silveira Barroso Alves
Davi da Silveira Barroso Alves
MMMarcos Nascimento Magalhães
Marcos Nascimento Magalhães

19 December 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SCSandra W. Cardoso
Sandra W. Cardoso
PLPaula M Luz
Paula M Luz
LVLuciane Velasque
Luciane Velasque
TTThiago S Torres
Thiago S Torres
ITIsabel C Tavares
Isabel C Tavares
BGBeatriz Grinsztejn
Beatriz Grinsztejn
World-wide, the notable expansion of HIV/AIDS treatment programs in resource-limited settings has lead to an increasing number of patients in need of second-line cART. To adequately address and prepare for this scenario, critical assessments of the outcomes of second-line cART are particularly relevant in settings where monitoring strategies may be inadequate. We evaluated virologic outcomes of second-line combination antiretroviral therapy (cART) among HIV-infected individuals from Brazil. This study was conducted at the Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, at Rio de Janeiro, Brazio. For this study we included all patients who started first-line and second-line cART between 2000 and 2013. Second-line cART required a switch in the anchor drug of first-line cART. We evaluated time from second-line start to virologic failure and factors associated with increased risk of failure using multivariable Cox proportional hazards regression models. Among the 1,311 patients who started first-line cART a total of 386 patients (29.5%) initiated second-line cART, out of which 35.0% and 60.6% switched from their first-line to their second-line cART when their HIV RNA was undetectable and after documented virologic failure, respectively. At second line cART initiation, median age was 38 years [interquartile range (IQR): 31-45years]. Median CD4 count was significantly different for patients starting second-line cART undetectable [412 cells/mm3 (IQR: 240-617)] compared to those starting second-line cART after documented virologic failure [230 cells/mm3 (IQR: 118-322.5)] (p < 0.01). Median time from second-line cART initiation to failure was also significantly different for patients starting second-line cART undetectable compared to those who with documented virologic failure (log-rank test p < 0.01). Multivariable Cox models showed that younger age, lower education, and HIV RNA level were independently associated with an increased hazard of second-line failure among those with documented virologic failure at start of second-line cART. We have shown that in a middle-income country with universal access to cART, having a detectable HIV RNA at the start of second-line cART as well as younger age and lower education negatively impact second-line outcomes. Our findings could guide HIV treatment efforts as to which strategies would help maximize the durability of these regimens.

9 January 2020 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
JFJulio Cezar Rodrigues Filho
Julio Cezar Rodrigues Filho
DNDenise Duprat Neves
Denise Duprat Neves
LVLuciane Velasque
Luciane Velasque
AMAnalúcia Abreu Maranhão
Analúcia Abreu Maranhão
MAMaria Helena de Araujo-Melo
Maria Helena de Araujo-Melo